Status:
NOT_YET_RECRUITING
Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma
Lead Sponsor:
Sohag University
Conditions:
Endometrial Carcinoma
Eligibility:
FEMALE
20-70 years
Phase:
NA
Brief Summary
Endometrial cancer, the most common gynecologic cancer worldwide, is steadily increasing in developed countries.The early-stage forms of endometrial cancer are usually highly curable by surgical treat...
Eligibility Criteria
Inclusion
- • Age group: Histologically diagnosed with primary endometrial carcinoma
- more than 20 years old.
- Any histological type of endometrial carcinoma
- Stage III, IV
- Stage one I or II with one or more of the following factors:
- Histologic grade 3 endometroid carcinoma with myometrial invasion still within half of the myometrium
- histological grade 1,2 endometroid carcinomas with invasion of over half of myometrium
- cervical stromal invasion
- vascular invasion; or
- serous carcinoma, clear cell carcinoma, or undifferentiated carcinoma
- performance status 0-2
- adequate function of all major organs
Exclusion
- • Pt has received prior radiation or chemotherapy.
- Pt with sarcomatous component
- Metastatic endometrial carcinoma
- Other malignancy
- Unfit patient for chemotherapy
Key Trial Info
Start Date :
August 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06102252
Start Date
August 15 2024
End Date
August 1 2025
Last Update
August 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university Hospital
Sohag, Egypt, Sohag